3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
1
Multiple Endocrine Neoplasia Type 2a
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Lung Diseases
1
Central Nervous System Neoplasms
1
Interventions
Carboplatin
3
zipalertinib
2
Cisplatin
2
zimberelimab
1
sacituzumab govitecan
1
repotrectinib
1
pembrolizumab
1
atezolizumab
1
alectinib
1
Pemetrexed
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Diseases
×
alectinib
×
30 days
×
Clear all
NCT06765109
2026-06-02
ALKAZAR
Nuvalent Inc.
Phase 3
Recruiting
450 enrolled